La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Medios Crescita futura

Future criteri di controllo 4/6

Medios prevede che gli utili e i ricavi cresceranno rispettivamente di 41.4% e 6.3% all'anno. Si prevede che l'EPS crescerà di 39.1% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 8.5% in 3 anni.

Informazioni chiave

41.4%

Tasso di crescita degli utili

39.1%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	20.3%
Tasso di crescita dei ricavi	6.3%
Rendimento futuro del capitale proprio	8.5%
Copertura analitica	Low
Ultimo aggiornamento	14 Aug 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Medios (ETR:ILM1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

May 21

Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 17

Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts

Jan 21

What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition

Jan 19

Is It Time To Consider Buying Medios AG (ETR:ILM1)?

Dec 24

Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week

Dec 09

The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It

Dec 08

Medios AG's (ETR:ILM1) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 22

What Can We Make Of Medios AG’s (ETR:ILM1) High Return On Capital?

Jun 22

Previsioni di crescita degli utili e dei ricavi

XTRA:ILM1 - Stime future degli analisti e dati finanziari passati (EUR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	2,244	49	54	69	5
12/31/2025	2,153	44	46	60	5
12/31/2024	1,997	25	36	45	5
6/30/2024	1,838	16	123	126	N/A
3/31/2024	1,810	18	84	85	N/A
12/31/2023	1,785	19	15	16	N/A
9/30/2023	1,743	19	28	30	N/A
6/30/2023	1,673	18	-51	-48	N/A
3/31/2023	1,650	18	11	14	N/A
12/31/2022	1,612	18	32	37	N/A
9/30/2022	1,581	13	32	39	N/A
6/30/2022	1,516	11	32	42	N/A
3/31/2022	1,436	10	25	38	N/A
12/31/2021	1,359	7	49	62	N/A
9/30/2021	1,163	11	-15	-5	N/A
6/30/2021	969	9	-24	-15	N/A
3/31/2021	780	6	-12	-6	N/A
12/31/2020	627	6	-43	-38	N/A
9/30/2020	599	6	0	2	N/A
6/30/2020	582	9	2	5	N/A
3/31/2020	566	10	-14	-11	N/A
12/31/2019	518	10	-3	0	N/A
9/30/2019	464	9	0	3	N/A
6/30/2019	413	7	-3	-1	N/A
3/31/2019	371	6	-4	-2	N/A
12/31/2018	329	4	-5	-3	N/A
9/30/2018	305	4	-3	-1	N/A
6/30/2018	282	3	-2	2	N/A
3/31/2018	268	4	N/A	1	N/A
12/31/2017	254	4	N/A	1	N/A
9/30/2017	224	1	N/A	-2	N/A
6/30/2017	193	-2	N/A	-5	N/A
3/31/2017	163	-3	N/A	-3	N/A
12/31/2016	133	-3	N/A	-2	N/A
12/31/2015	58	1	N/A	1	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di ILM1 ( 41.4% all'anno) è superiore al tasso di risparmio ( 0.8% ).

Guadagni vs Mercato: Si prevede che gli utili di ILM1 ( 41.4% all'anno) cresceranno più rapidamente del mercato German ( 20% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di ILM1 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di ILM1 ( 6.3% all'anno) crescerà più rapidamente del mercato German ( 5.2% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di ILM1 ( 6.3% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di ILM1 sarà basso tra 3 anni ( 8.5 %).

Medios Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Consensus EPS estimates fall by 15%

Price target decreased by 12% to €32.40

Price target decreased by 14% to €34.60

Price target decreased by 19% to €34.25

Price target decreased by 7.4% to €42.40

Consensus forecasts updated

Recent updates

Consensus EPS estimates fall by 15%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

New minor risk - Shareholder dilution

Price target decreased by 12% to €32.40

Medios AG (XTRA:ILM1) acquired Ceban B.V. from Bencis Capital Partners B.V.

Medios (ETR:ILM1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

First quarter 2024 earnings released: EPS: €0.17 (vs €0.20 in 1Q 2023)

Price target decreased by 14% to €34.60

Full year 2023 earnings: EPS and revenues miss analyst expectations

Medios AG (XTRA:ILM1) agreed to acquire Ceban B.V. from Bencis Capital Partners B.V. for € 259 million.

Investor sentiment improves as stock rises 21%

Medios AG (XTRA:ILM1) agreed to acquire Ceban B.V. from Bencis Capital Partners B.V. for € 259 million.

Medios AG, Annual General Meeting, Jun 26, 2024

Medios AG to Report Q2, 2024 Results on Aug 13, 2024

Price target decreased by 19% to €34.25

Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Medios AG to Report Q3, 2023 Results on Nov 14, 2023

Second quarter 2023 earnings released: EPS: €0.19 (vs €0.21 in 2Q 2022)

First quarter 2023 earnings released: EPS: €0.20 (vs €0.21 in 1Q 2022)

Full year 2022 earnings released: EPS: €0.77 (vs €0.37 in FY 2021)

Price target decreased by 7.4% to €42.40

Is Medios AG (ETR:ILM1) Trading At A 39% Discount?

Medios AG to Report First Half, 2023 Results on Aug 14, 2023

Investor sentiment improved over the past week

Is Medios (ETR:ILM1) Using Too Much Debt?

Medios AG (XTRA:ILM1) entered into a purchase agreement to acquire Blisterzentrum Baden-Württemberg Gmbh.

Consensus forecasts updated

Third quarter 2022 earnings: EPS exceeds analyst expectations

Price target decreased to €45.80

Third quarter 2022 earnings: EPS exceeds analyst expectations

Is It Too Late To Consider Buying Medios AG (ETR:ILM1)?

Investor sentiment deteriorated over the past week

Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Is Now The Time To Look At Buying Medios AG (ETR:ILM1)?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Is Medios (ETR:ILM1) Using Too Much Debt?

Consensus forecasts updated

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to €54.80

Investor sentiment deteriorated over the past week

Here's Why I Think Medios (ETR:ILM1) Is An Interesting Stock

What Does Medios AG's (ETR:ILM1) Share Price Indicate?

Medios AG Provides Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Medios (ETR:ILM1) Has A Pretty Healthy Balance Sheet

Medios AG (XTRA:ILM1) entered into an agreement to acquire NewCo Pharma GmbH.

Price target increased to €51.75

Third quarter 2021 earnings released: EPS €0.18 (vs €0.07 in 3Q 2020)

Is There Now An Opportunity In Medios AG (ETR:ILM1)?

Consensus forecasts updated

Second quarter 2021 earnings released: EPS €0.17 (vs €0.06 in 2Q 2020)

Medios AG's (ETR:ILM1) Intrinsic Value Is Potentially 35% Above Its Share Price

What Is Medios AG's (ETR:ILM1) Share Price Doing?

First quarter 2021 earnings released: EPS €0.15 (vs €0.15 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS €0.39 (vs €0.67 in FY 2019)

Medios AG Reiterates Revenue Guidance for the Financial Year 2021

New 90-day low: €34.80

Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Medios AG (XTRA:ILM1) completed the acquisition of CRANACH PHARMA GmbH from BMSH GmbH.

Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts

What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition

New 90-day high: €38.50

Is It Time To Consider Buying Medios AG (ETR:ILM1)?

Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week

The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It

Price target raised to €40.33

Medios AG to Report Q3, 2021 Results on Nov 09, 2021